- Home
- MDGL vs HRL Comparison
MDGL vs HRL Comparison
Compare MDGL & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | HRL |
|---|---|---|
| Founded | 2011 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.2B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MDGL | HRL |
|---|---|---|
| Price | $429.21 | $20.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 10 |
| Target Price | ★ $685.22 | $25.31 |
| AVG Volume (30 Days) | 273.9K | ★ 4.7M |
| Earning Date | 11-03-2026 | 12-03-2026 |
| Dividend Yield | N/A | ★ 5.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | $180,133,000.00 | ★ $12,106,160,000.00 |
| Revenue This Year | $59.43 | $0.18 |
| Revenue Next Year | $38.83 | $1.84 |
| P/E Ratio | ★ N/A | $28.59 |
| Revenue Growth | N/A | ★ 1.55 |
| 52 Week Low | $399.00 | $18.96 |
| 52 Week High | $615.00 | $26.60 |
Technical Indicators
Market Signals| Indicator | MDGL | HRL |
|---|---|---|
| Relative Strength Index (RSI) | 29.53 | 54.18 |
| Support Level | $416.21 | $20.38 |
| Resistance Level | $546.29 | $21.38 |
| Average True Range (ATR) | 16.26 | 0.40 |
| MACD | -1.31 | 0.16 |
| Stochastic Oscillator | 10.31 | 79.13 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About HRL Hormel Foods Corporation
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (less than 6%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.